CCL2 and COVID-19: A single-cell study of bronchoalveolar lavage fluid (BALF) in intubated COVID-19 patients identified two inflammatory macrophage subsets—one characterized by CCL2, CCL3, and CXCL10 expression and a second by FCN1 and S100A8—as potential mediators of pathology in this late-stage disease [4].